ALK c.353C>G ;(p.A118G)

Variant ID: 2-30143173-G-C

NM_004304.4(ALK):c.353C>G;(p.A118G)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.

Plos One
Marteau, Theresa M TM; Aveyard, Paul P; Munafò, Marcus R MR; Prevost, A Toby AT; Hollands, Gareth J GJ; Armstrong, David D; Sutton, Stephen S; Hill, Chloe C; Johnstone, Elaine E; Kinmonth, Ann Louise AL
Publication Date: 2012

Variant appearance in text: ALK: A118G
PubMed Link: 22509402
Variant Present in the following documents:
  • Main text
  • pone.0035249.pdf
  • pone.0035249.s002.pdf
View BVdb publication page



Translational genetic approaches to substance use disorders: bridging the gap between mice and humans.

Human Genetics
Palmer, Abraham A AA; de Wit, Harriet H
Publication Date: 2012-06

Variant appearance in text: ALK: A118G
PubMed Link: 22170288
Variant Present in the following documents:
  • Main text
View BVdb publication page



Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Bmc Public Health
Marteau, Theresa M TM; Munafò, Marcus R MR; Aveyard, Paul P; Hill, Chloe C; Whitwell, Sophia S; Willis, Thomas A TA; Crockett, Rachel A RA; Hollands, Gareth J GJ; Johnstone, Elaine C EC; Wright, Alison J AJ; Prevost, A Toby AT; Armstrong, David D; Sutton, Stephen S; Kinmonth, Ann Louise AL
Publication Date: 2010-11-09

Variant appearance in text: ALK: A118G
PubMed Link: 21062464
Variant Present in the following documents:
  • 1471-2458-10-680.pdf
View BVdb publication page